- Anomalous Right Coronary Artery From the Left Coronary Sinus With an Interarterial Course: Is It Really Dangerous?
-
Lee BY
- KMID: 1826015
- Korean Circ J.
- 2009 May;39(5):175-179.
- doi: 10.4070/kcj.2009.39.5.175
Anomalous origin of the right or left coronary artery from the contralateral sinus of Valsalva is often asymptomatic, but many patients, particularly young ones, present with sudden death or myocardial... -
- CITED
-
- Close
- SHARE
-
- Close
- An Unusual Type of Hypertrophic Cardiomyopathy
-
Seo HS, Kim DH, Kim EJ, Yoo HY, Kim C, Lee CH, Kim BY, Chung CH, Suh J, Cho YH, Lee NH
- KMID: 1826022
- Korean Circ J.
- 2009 May;39(5):213-216.
- doi: 10.4070/kcj.2009.39.5.213
An unusual type of hypertrophic cardiomyopathy was diagnosed in a 17-year-old girl who presented with dyspnea on exertion. The hypertrophied myocardium was localized to the anterior portion of the left... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Aortopulmonary Fistula Caused by a Huge Thoracic Aortic Aneurysm
-
Kim SE, Kim HJ, Lee SH, Lee KH, Kim KY, Yoon JW, Bae SK, Choi SU, Rho BH
- KMID: 1826021
- Korean Circ J.
- 2009 May;39(5):209-212.
- doi: 10.4070/kcj.2009.39.5.209
Aortopulmonary fistula is an uncommon but often fatal condition resulting as a late complication of an aortic aneurysm. The most common cause is erosion of a false aneurysm of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
-
Kim SS, Jeong MH, Sim DS, Hong YJ, Kim JH, Ahn YK, Kang JC
- KMID: 1826020
- Korean Circ J.
- 2009 May;39(5):205-208.
- doi: 10.4070/kcj.2009.39.5.205
Drug-eluting stents (DESs) are the treatment of choice for obstructive coronary artery disease when percutaneous intervention is feasible. However, late stent thrombosis seems to occur more frequently with DESs and... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension
-
Jung AD, Kim W, Park SH, Park JS, Cho SC, Hong SB, Hwang SH, Kim W
- KMID: 1826016
- Korean Circ J.
- 2009 May;39(5):180-184.
- doi: 10.4070/kcj.2009.39.5.180
BACKGROUND AND OBJECTIVES: Several studies have shown that angiotensin II receptor blockers (ARBs) improve endothelial function and arterial stiffness. Telmisartan is a highly selective ARB that activates peroxisome proliferator-activated receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- Enhanced Cardiomyogenic Differentiation of P19 Embryonal Carcinoma Stem Cells
-
Yang J, Ko SJ, Kim BS, Kim HS, Park S, Hong D, Hong SW, Choi JH, Park CY, Choi SC, Hong SJ, Lim DS
- KMID: 1826019
- Korean Circ J.
- 2009 May;39(5):198-204.
- doi: 10.4070/kcj.2009.39.5.198
BACKGROUND AND OBJECTIVES: We investigated the effects of different concentrations of serum, 5-azacytidine, and culture time on the cardiomyogenic differentiation of P19 embryonal carcinoma stem cells in the course of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
-
Park JH, Oh YS, Kim JH, Chung WB, Oh SS, Lee DH, Choi YS, Shin WS, Park CS, Youn HJ, Chung WS, Lee MY, Seung KB, Rho TH, Kim JH, Hong SJ
- KMID: 1826017
- Korean Circ J.
- 2009 May;39(5):185-189.
- doi: 10.4070/kcj.2009.39.5.185
BACKGROUND AND OBJECTIVES: It is known that angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers (ACEIs and ARBs, respectively) are effective in preventing atrial fibrillation (AF) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation
-
Park KH, Jeong MH, Lee MG, Ko JS, Lee SE, Kang WY, Kim SH, Sim DS, Yoon NS, Youn HJ, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 1826018
- Korean Circ J.
- 2009 May;39(5):190-197.
- doi: 10.4070/kcj.2009.39.5.190
BACKGROUND AND OBJECTIVES: Triple anti-platelet therapy is known to prevent restenosis after drug-eluting stent (DES) implantation. However, there is little available data concerning the efficacy of triple anti-platelet therapy for... -
- CITED
-
- Close
- SHARE
-
- Close
